AMGEN Inc

NASDAQ: AMGN
$289.02
+$0.15 (+0.1%)
Closing Price on February 4, 2025

AMGN Articles

The August 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
The July 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The July 14 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The June 30 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
The biotech industry has made a splash in 2017, outperforming practically all the broad markets. With this incredible display, it's no wonder that investor interest in this particular industry has...
The June 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
The top analyst upgrades, downgrades and other research calls from Friday include AK Steel, Altice USA, Biogen, Caterpillar, Gilead Sciences and Oracle.
Coherus Biosciences saw its shares crater on Monday after the company announced that it received a complete response letter from the FDA regarding its biologics license application for a...
The May 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
The May 15 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed.
The April 28 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed.
The April 13 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed.
24/7 Wall St. has put together a preview of Boeing, PepsiCo and other top companies scheduled to report their quarterly results on Wednesday.
The March 31 short interest data have been compared with the previous report, and short interest decreased in most of the selected biotech stocks.
The health care sector in general has rallied since Trump took over the presidency, but now that his repeal of the ACA fell through, the health care rally is called into question.
AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.